Literature DB >> 10093893

Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemia.

A Oguogho1, M Mehrabi, H Sinzinger.   

Abstract

Oxidation injury results in foam cell formation, which is known to be a central mechanism in atherogenesis. We investigated in this study whether 8-epi-prostaglandin (PG) F2 alpha, an in vivo indicator of oxidative stress, is elevated in hyperlipoproteinemia. The isoprostane 8-epi-PGF2 alpha levels in plasma, serum and urine were determined in 123 patients (67 m, 56 f; 17-60 years) suffering from familial heterozygous hypercholesterolemia (FH). A group of 99 normocholesterolemic adults (51 m, 48 f; 20-63 years) served as controls. Plasma, serum and urine levels of 8-epi-PGF2 alpha were significantly (p < 0.01) higher in the FH group. Smokers showed elevated 8-epi-PGF2 alpha levels; however, no correlation was observed to hypertension, age and sex. Successful dietary and drug treatment of FH patients resulted in a significant decrease in 8-epi-PGF2 alpha levels in plasma, serum and urine. These findings indicate that FH is associated with increased oxidation injury, which is beneficially influenced by successful dietary and/or drug treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10093893

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  4 in total

1.  Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems.

Authors:  H Sinzinger; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

2.  Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.

Authors:  Ghainsom D Kom; Edzard Schwedhelm; Renke Maas; Lydia Schneider; Ralf Benndorf; Rainer H Böger
Journal:  Br J Clin Pharmacol       Date:  2007-01-03       Impact factor: 4.335

3.  Oxidation injury in patients receiving HMG-CoA reductase inhibitors: occurrence in patients without enzyme elevation or myopathy.

Authors:  Helmut Sinzinger; Fahdi Chehne; Graziana Lupattelli
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries.

Authors:  L Siangjong; D H Goldman; T Kriska; K M Gauthier; E M Smyth; N Puli; G Kumar; J R Falck; W B Campbell
Journal:  Acta Physiol (Oxf)       Date:  2016-01-04       Impact factor: 6.311

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.